QLT Inc.
Records under this name other than the patents QLT Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,691,265 | Drug delivery methods, structures, and compositions for nasolacrimal system Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,922,702 | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,998,497 | Nasolacrimal drainage system implants for drug therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,376,590 | Sustained delivery formulations of risperidone compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,013,809 | Sustained delivery formulations of risperidone compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,747,884 | Nasolacrimal drainage system implants for drug therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,712,475 | Sustained delivery formulations of risperidone compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,678,829 | Oculoselective Drugs and Prodrugs Formerly held In force · High confidence | In force | High confidence | |
| US 8,628,792 | Drug cores for sustained release of therapeutic agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,702,643 | Lacrimal implants and related methods Formerly held In force · From the USPTO record | In force | From the USPTO record |